Lilly's Retevmo wins US nod for specific lung, thyroid cancers
admin 12th May 2020 Uncategorised 0The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process
More: Lilly's Retevmo wins US nod for specific lung, thyroid cancers
Source: News